Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 2Completed 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Tumor-Agnostic 1Myeloid 1Gastrointestinal 1Dermatologic 1Classical hematology 1CNS 1Breast 1

Conditions

Breast Neoplasms 1Blood Loss, Surgical 1

Interventions

pembrolizumab 78Fulvestrant 76Carboplatin 74Trastuzumab 71Capecitabine 70Letrozole 63Cyclophosphamide 61Paclitaxel 60Specimen Handling 54pertuzumab 52Docetaxel 50abemaciclib 46ribociclib 45Anastrozole 36Magnetic Resonance Spectroscopy 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Blood Specimen Collection 33exemestane 32Tamoxifen 32Biopsy 32sacituzumab govitecan 31Gemcitabine 30Epirubicin 29pyrotinib 28palbociclib 28Drug Therapy 28Surveys and Questionnaires 27Injections 27eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Tranexamic Acid × Breast × Clear all
NCT06428682 2024-06-05

Role of TXA in Patients Undergoing Breast Free Flap Reconstruction

University of Virginia

Phase 4 Recruiting
100 enrolled
Breast

Breast Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon âš¡